ACE and Alzheimer disease: Because approximately 4–5% of the general population are carriers of different LoF ACE mutations, we hypothesized that subjects with heterozygous LoF ACE mutations are at risk for the development of Alzheimer’s disease, especially for those LoF mutations that result in reduced ACE activity.